| Events by John E. Calfee |
| Resident Scholar |
 |
|
|
| [Hide Abstracts] |
|
|
Implications of Medicare Part D
|
|
Tuesday, October 14, 2008
|
|
| This event will discuss the impact of the Medicare Part D program on the U.S. health care system. |
|
|
Autism's False Prophets
|
|
Friday, October 10, 2008
|
|
| Experts in the field of autism will discuss current ideas about causes and cures of the disease. |
|
|
Innovation and Technology Adoption in Health Care Markets
|
|
Monday, September 22, 2008
|
|
| University of Chicago health economists Anupam B. Jena and Tomas J. Philipson discuss their new book, Innovation and Technology Adoption in Health Care Markets. |
|
|
Off-Label Uses of Approved Drugs: Medicine, Law, and Policy
|
|
Wednesday, May 21, 2008
|
|
| At this AEI Legal Center event, experts on both law and health care will present papers on the law, economics, medicine, and public policy of off-label marketing. |
|
|
Oncology Drug Development: Rethinking FDA Oversight
|
|
Thursday, March 13 - Friday, March 14, 2008
|
|
| At this conference, a group of experts will delve into such topics as clinical trial design, statistical analysis of trial results, and the feedback process from FDA regulators to pharmaceutical |
|
|
The Vioxx Settlement
|
|
Monday, January 7, 2008
|
|
| At this cosponsored AEI/Federalist Society event, experts will explore the Vioxx settlement, whether it can bear legal challenge, and the ethical issues surrounding Vioxx litigation? |
|
|
Vaccinated: The Quest for New Vaccines Yesterday and Today
|
|
Tuesday, October 9, 2007
|
|
| At this event, Offit--through his story of Hilleman’s career--will share his observations on new vaccine development in today’s very different environment, with its threat of liability litigation and |
|
|
Biotechnology and the Patent System: The Economic Implications of the Proposed Patent Reform Act of 2007
|
|
Tuesday, September 25, 2007
|
|
| The authors will discuss the importance of patents in the development of new biotechnology drugs and diagnostic tests and the recent economic and legal thinking on the dynamics of patent law. |
|
|
What Should Congress Do about Generic or Follow-On Biologic Drugs?
|
|
Monday, June 11, 2007
|
|
| Panelists will discuss regulation (including in Europe, which already has a follow-on biologic pathway), manufacturing, economics, and intellectual property of biologic drugs. |
|
|
Can Government Price Negotiation Work for the Medicare Drug Benefit?
|
|
Friday, January 19, 2007
|
|
| Should the government negotiate the prices of pharmaceuticals covered by the new Medicare Part D prescription drug benefit? |
|
|
| Total Records: 50 |
|
|
|
|
|
|
| Research Areas |
| Advertising |
| Food and Drug Administration policies |
| Health care policy |
| Pharmaceuticals |
| Tobacco |
| Tort liability system |
|
| Downloads |
|
|
|
| Contact Information |
John E. Calfee
American Enterprise Institute
1150 Seventeenth Street, N.W.
Washington, DC 20036
Phone: 202-862-7175
Assistant: 202-862-7183
Fax: 202-862-7177
E-mail: CalfeeJ@aei.org
|
|
| Latest Book |
|
 |
|
|
Biotechnology and the Patent System
|
| This book offers a timely discussion of biotechnology patent reform. [Read More] |
|
|
|
|
